BCL2L12 and glioblastoma: Bcl2L12 is a potential prognostic factor, as glioblastoma patients with high-level overexpression of Bcl2L12 mRNA have shorter progression-free survival than patients with low or underexpression of Bcl2L12 [43,44,45].